| Jun 13 |
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
|
| Jun 12 |
Summit (SMMT) Stock Surges 57% in the Past Month: Here's Why
|
| Jun 12 |
Viridian (VRDN) Up 10% on Clinical Updates for Eye Disease Drug
|
| Jun 10 |
Arcutis Announces New Long-Term Data of Roflumilast Cream 0.15% for the Treatment of Mild to Moderate Atopic Dermatitis (AD) in Adults and Children Down to Age Six Presented at Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference
|
| Jun 6 |
Amgen's (AMGN) Uplizna Meets Study Goal for Rare Disease
|
| Jun 6 |
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
|
| Jun 5 |
Arcutis Announces Multiple Abstracts, Including Oral Presentation, Accepted at the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference
|
| Jun 4 |
Agios (AGIO) Up 21% on Upbeat Data From 2nd Thalassemia Study
|
| Jun 3 |
Arcutis to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
|
| May 31 |
Are Medical Stocks Lagging Arcutis Biotherapeutics (ARQT) This Year?
|
